| Literature DB >> 29255413 |
Andreas Stomby1,2, Julia Otten1, Mats Ryberg1, Lars Nyberg3,4,5, Tommy Olsson1, Carl-Johan Boraxbekk3,6,7.
Abstract
Type 2 diabetes is associated with impaired episodic memory functions and increased risk of different dementing disorders. Diet and exercise may potentially reverse these impairments. In this study, sedentary individuals with type 2 diabetes treated by lifestyle ± metformin were randomized to a Paleolithic diet (PD, n = 12) with and without high intensity exercise (PDEX, n = 12) for 12 weeks. Episodic memory function, associated functional brain responses and hippocampal gray matter volume was measured by magnetic resonance imaging. A matched, but not randomized, non-interventional group was included as a reference (n = 6). The PD included a high intake of unsaturated fatty acids and protein, and excluded the intake of dairy products, grains, refined sugar and salt. The exercise intervention consisted of 180 min of supervised aerobic and resistance exercise per week. Both interventions induced a significant weight loss, improved insulin sensitivity and increased peak oxygen uptake without any significant group differences. Furthermore, both interventions were associated with increased functional brain responses within the right anterior hippocampus, right inferior occipital gyrus and increased volume of the right posterior hippocampus. There were no changes in memory performance. We conclude that life-style modification may improve neuronal plasticity in brain areas linked to cognitive function in type 2 diabetes. Putative long-term effects on cognitive functions including decreased risk of dementing disorders await further studies. Clinical trials registration number: Clinicaltrials. gov NCT01513798.Entities:
Keywords: episodic memory; exercise; magnetic resonance imaging; paleolithic diet; type 2 diabetes
Year: 2017 PMID: 29255413 PMCID: PMC5722796 DOI: 10.3389/fnagi.2017.00391
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Anthropometric, biochemical and fitness measurements [medians (IQR), (range) is given for age].
| Gender (Men/Women) | 9/3 | 8/4 | ||
| Age (years) | 59 (44–66) | 61 (58–69) | ||
| Diabetes duration (years) | 3 (6) | 5.5 (7) | ||
| BMI (kg × m−2) | 30.6 (4.1) | 28.4 (4) | 32.1 (7.6) | 29.4 (7.4) |
| Waist (cm) | 110 (14) | 99 (15) | 108 (20) | 99 (23) |
| Total body fat (%) | 36.1 (6.5) | 31.7 (9.3) | 37.7 (9.6) | 33.3 (10.4) |
| Total lean mass (kg) | 56.9 (15.9) | 55.2 (12.4) | 61.0 (24.9) | 60.7 (26.6) |
| HbA1c (mmol/mol) | 50 (10) | 41 (2) | 57 (17) | 42 (6) |
| fP-Insulin (IU) | 23 (12) | 11.5 (6.5) | 16.5 (10.8) | 11.0 (5.9) |
| fB-Glucose | 7.5 (1.8) | 6.1 (1.2) | 9.6 (3.6) | 7.2 (1.5) |
| HOMA-IR | 7.2 (3.6) | 3.0 (2.5) | 7.7 (5) | 3.3 (1.6) |
| fS-Cholesterol (mmol/l) | 4.5 (2.0) | 4.2 (1.5) | 4.3 (1.3) | 3.8 (0.9) |
| fS-LDL (mmol/l) | 2.1 (1.0) | 2.6 (1.4) | 2.3 (1.4) | 2.2 (0.8) |
| fS-HDL (mmol/l) | 0.8 (0.2) | 0.9 (0.24) | 1.1 (0.3) | 1.1 (0.22) |
| fS-Triglycerides (mmol/l) | 2.3 (2.8) | 1.04 (1.2) | 1.7 (1.5) | 1.1 (0.4) |
| fS-BDNF (ng/ml) | 26.1 (8.3) | 22.8 (8.2) | 27.6 (7.3) | 21.7 (15.9) |
| Peak oxygen uptake (ml/min/kg) | 23.7 (6.3) | 28.2 (9.9) | 22.1 (5.0) | 26.5 (5.7) |
P < 0.01 for change from baseline—12 weeks within each group tested with Wilcoxon signed ranks test.
P < 0.01 for difference between the groups at baseline tested with Mann-Whitney U test. There were no significant group differences in change from baseline—12 weeks.
Reported energy intake, macronutrient composition and physical activity energy expenditure (PAEE) at baseline and 12 weeks [Medians (IQR)].
| Total energy intake (kCal) | 2,064 (805) | 1,446 (880) | 1,728 (866) | 1,307 (493) |
| Protein (E%) | 17 (4) | 24 (4) | 19 (4) | 26 (8) |
| Carbohydrate (E%) | 40 (10) | 26 (14) | 39 (16) | 25 (5) |
| Total fat (E%) | 38 (5) | 43 (10) | 35 (14) | 46 (12) |
| Saturated fat (E%) | 15 (4) | 9 (3) | 13 (5) | 9 (3) |
| Mono-unsaturated fat (E%) | 14 (3) | 22 (8) | 14 (5) | 23 (8) |
| Poly-unsaturated fat (E%) | 5 (2) | 8 (2) | 6 (2) | 9 (4) |
| PAEE (kCal/24h) | 935 (303) | 881 (280) | 973 (1,181) | 931 (642) |
P < 0.05,
P < 0.01 for change from baseline—2 weeks within each group tested with Wilcoxon signed ranks test. There were no significant differences between groups. E%, energy percent.
Figure 1Regions with a significant effect of time during memory encoding in the intervention groups (P < 0.001, extension >10 voxels, uncorrected; warm colors indicate clusters with increased BOLD response and cold colors indicate clusters with decreased BOLD response; color scale in T scores, range 0.03–4.3). The bar charts display the mean (SEM) %BOLD signal change during memory encoding in (A) right inferior occipital cortex, (B) left superior parietal gyrus, (C) left angular gyrus. Black = PD (n = 12), gray = PDEX (n = 12), white = reference group (n = 6). ns, not significant.
Brain regions with a significant main effect of time (P < 0.001, extension > 10 voxels) during memory encoding.
| L Superior parietal gyrus | 7 | −24 | −64 | 56 | 216 | 4.36 | Decrease |
| R Inferior occipital gyrus | 19 | 46 | −74 | −6 | 184 | 4.04 | Increase |
| L Angular gyrus | 39/48/22/41/40 | −48 | −50 | 28 | 136 | 4.04 | Decrease |
| R Hippocampus | 20 | 32 | −12 | −16 | 248 | 3.79 | Increase |
Brain region is given for the peak BOLD response. L, Left; R, Right; BA, Brodmann areas included in cluster. Volume is given in [mm3].
The cluster in R Hippocampus was found in a region of interest analysis of the hippocampus.
Figure 2A ROI analysis of the hippocampus revealed increased functional brain response in the right anterior hippocampus in the intervention groups (time effect P < 0.001, extension >5 voxels, uncorrected; color scale in T scores range 0.03–5.7; Y = −12). (A) The mean (SEM) peak %BOLD signal change in the cluster at baseline and 12 weeks. Black = PD (n = 12), gray = PDEX (n = 12), white = reference group (n = 6). (B) The association between change in serum BDNF levels and %BOLD signal change in the right anterior hippocampus (r = 0.58, P = 0.007). Dots = PD, Squares = PDEX. Gray areas = 95% confidence interval.
Figure 3Increased volume in the right posterior hippocampus in the intervention groups (P < 0.05 FWE corrected, extension >5 voxels; color scale in T scores range 0.03–5.7; Y = −38). Bars display the mean (SEM) beta weights in the cluster in right posterior hippocampus. Black = PD (n = 12), gray = PDEX (n = 11), white = Reference group (n = 5).